FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/03/2026
Voltar para busca
Dado oficial do USPTO
NORTHX BIOLOGICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 42
Data de depósito
14/08/2023
Data de registro
05/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/08/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
SE
Examinador
REID, CAILE MAUREEN
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized dark blue wording "NORTHX" stacked above the stylized light blue wording "BIOLOGICS". The wording is to the right of a design of two incomplete triangles overlapping, wherein the body of each triangle is colored dark blue, and the right side of the left-hand triangle is colored with a beige line, overlapped by the left side of the right-hand triangle colored with a light blue line.
Titulares e representantes
Titulares
NorthX Biologics AB
NorthX Biologics Matfors AB
Representantes
Alexander Lazouski Lazouski IP LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and scienceespecially proteinsenzymes and modifications thereof
Classe 5
Diagnostic preparations for pharmaceutical purposes; a full line of medicinal products; biological preparations for medical purposes; chemical preparations for medical purposes; diagnostic preparations for medical purposes; biological reagents for medical use; somatic cell therapy productsmuscle cellsblood cellsskin cells and nerve cells for medical use; pharmaceutical preparations for gene therapy usevirusviral vectorplasmid DNA material to be used in gene therapy applications for medical purposes; cell-based preparationsplasmid DNA and mRNA cell therapy for medical purposes; nucleic acid preparations being nucleic acid sequences for medical purposes; vaccines; recombinant proteins arrays for medical diagnosis purposes; therapeutic antibodies for medical purposes; microbial expressed protein arrays for medical diagnosis purposes; DNA vaccines; DNA plasmids being vaccines and pharmaceutical preparations for use in gene therapies
Classe 9
Scientific apparatus and instruments being medical laboratory research instruments for controllingmeasuringacceleratingtransporting chemicals for use in biochemical and genetic research; Scientific apparatus and instrumentsapparatus and instruments being medical laboratory research instruments for use in gene therapyplasmid DNA productioncell banking and DNA sequencing
Classe 42
Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research servicestechnology advisory services related to pharmaceutical research and developmentdevelopment of gene therapy productsgenetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific researchconducting clinical trials for others; medical and scientific researchconducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks.
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2026
FIMP
FINAL DISPOSITION PROCESSED
13/02/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/11/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/11/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
26/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/06/2025
PUBO
PUBLISHED FOR OPPOSITION
17/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/05/2025
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/04/2025
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/04/2025
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
24/04/2025
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
24/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
27/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
22/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/03/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/10/2024
GNFR
FINAL REFUSAL E-MAILED
07/10/2024
CNFR
FINAL REFUSAL WRITTEN
07/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/08/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/08/2024
RFNT
REFUSAL PROCESSED BY IB
22/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/04/2024
RFRR
REFUSAL PROCESSED BY MPU
28/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/04/2024
CNRT
NON-FINAL ACTION WRITTEN
16/04/2024
DOCK
ASSIGNED TO EXAMINER
15/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/11/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
17/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NORTHX BIOLOGICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.